Free Trial

Denali Therapeutics (DNLI) Earnings Date, Estimates & Call Transcripts

Denali Therapeutics logo
$25.05 -3.40 (-11.95%)
(As of 11/15/2024 08:54 PM ET)

Denali Therapeutics Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 25Estimated
Actual EPS
(Nov. 6)
-$0.63 Missed By -$0.03
Consensus EPS
(Nov. 6)
-$0.60

Denali Therapeutics issued Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.63, which missed the consensus estimate of -$0.60 by $0.03. With a trailing EPS of -$2.76, Denali Therapeutics' earnings are expected to decrease next year, from ($2.69) to ($2.90) per share.

DNLI Upcoming Earnings

Denali Therapeutics' next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules.


Skip Charts & View Estimated and Actual Earnings Data

DNLI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DNLI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Denali Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244-$0.81-$0.61-$0.71
Q2 20245-$0.78-$0.62-$0.69
Q3 20245-$0.76-$0.49-$0.65
Q4 20245-$0.87-$0.71-$0.78
FY 202419-$3.22-$2.43-$2.82
Q1 20253-$0.83-$0.69-$0.76
Q2 20253-$0.83-$0.67-$0.76
Q3 20253-$0.84-$0.67-$0.77
Q4 20252-$0.84-$0.65-$0.75
FY 202511-$3.34-$2.68-$3.04
Q1 20261-$0.72-$0.72-$0.72
Q2 20261-$0.75-$0.75-$0.75
Q3 20261-$0.73-$0.73-$0.73

Denali Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/25/2025
(Estimated)
------- 
11/6/2024Q3 2024-$0.60-$0.63 -$0.03-$0.63$6.30M-
8/1/2024Q2 2024-$0.68-$0.59+$0.09-$0.59$10.00M$1.00M  
5/7/2024Q1 2024-$0.69-$0.68+$0.01-$0.68$14.02M-  
2/27/2024Q4 2023-$0.81-$0.86 -$0.05-$0.86$3.38M-  
11/7/2023Q3 2023-$0.81-$0.72+$0.09-$0.72$11.16M$1.30M  
8/8/2023Q2 2023-$0.69$1.30+$1.99$1.30$39.51M$294.10M  
The Harvard Business School proved his stock picking system works (Ad)

If you missed our last email, I hope you see this one. You see, this Tuesday afternoon we’re sitting down with the #1 ranked stock picker in North America. A man who’s beat out 16,000 stock market professionals on Sum Zero to claim the top spot… He was amongst the first to recommend many of today’s most dominant companies, including both Apple and Nvidia. And for the first time on a large scale, he’s going to share the stock rating system that made it all possible… Not only has this system been proven to generate significant alpha by The Harvard Business School… It also earned a patent from the US government… The technology behind this system is out of this world, and our #1 stock picker has agreed to let us test a number of stocks against it.

Follow this link here we’ll add you to the guest list.
5/8/2023Q1 2023-$0.70-$0.80 -$0.10-$0.80$29.88M$35.14M  
2/27/2023Q4 2022-$0.77-$0.75+$0.02-$0.75$11.29M$10.28M  

Denali Therapeutics Earnings - Frequently Asked Questions

Denali Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on DNLI's earnings history.

In the previous quarter, Denali Therapeutics (NASDAQ:DNLI) missed the analysts' consensus estimate of ($0.60) by $0.03 with a reported earnings per share (EPS) of ($0.63). Learn more on analysts' earnings estimate vs. DNLI's actual earnings.

Denali Therapeutics (NASDAQ:DNLI) has a recorded annual revenue of $330.53 million.

Denali Therapeutics (NASDAQ:DNLI) has a recorded net income of -$145.22 million. DNLI has generated -$2.76 earnings per share over the last four quarters.

Denali Therapeutics's earnings are expected to decrease from ($2.69) per share to ($2.90) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:DNLI) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners